Search

Your search keyword '"Salvadori, Nicola"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Salvadori, Nicola" Remove constraint Author: "Salvadori, Nicola" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
165 results on '"Salvadori, Nicola"'

Search Results

6. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis

10. Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

11. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

13. Predictive value for cerebrospinal fluid Alzheimer’s disease profile of different measures of verbal episodic memory in patients with mild cognitive impairment

14. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)

15. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

16. Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts

24. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly

25. Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults.

26. White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers

29. Late‐onset epilepsy with unknown etiology: A pilot study on neuropsychological profile, cerebrospinal fluid biomarkers, and quantitative EEG characteristics

30. Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics

35. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

36. Age Modifies the Association Between Apolipoprotein E Genotype and Alzheimer's Disease: A CSF Biomarker-Based Multicentric Case-Control Study

39. Additional file 5: of Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

40. Additional file 2: of Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

41. Additional file 4: of Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

42. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

43. [P1-237]: DIFFERENTIAL ROLE OF CSF FATTY ACID BINDING PROTEIN 3, α-SYNUCLEIN AND ALZHEIMER's DISEASE CORE BIOMARKERS IN LEWY BODY DISORDERS AND ALZHEIMER's DEMENTIA

46. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes

47. Performance Evaluation of an Automated ELISA System for Alzheimer’s Disease Detection in Clinical Routine

48. P1-194: Diagnostic Performance of an Automated Elisa System for Alzheimer’s Disease Detection

49. P3-056: Back-Translation of EEG/ERP Markers from Amnestic MCI Patients to Healthy Young Volunteers in the Pharmacog Project

50. P1-363: Not Yet MCI: How to Detect Subtle Cognitive Impairment?

Catalog

Books, media, physical & digital resources